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ORIGINAL ARTICLE
Background/Aims: Paraquat-induced lung injury has been considered a progressive and irreversible disease.
The purpose of this study was to report the long-term evolution of lung lesions in eight survivors with significant
paraquat-induced lung injuries who could be followed-up for longer than 6 months.
Methods: We retrospectively examined high-resolution computed tomography and pulmonary function test of
eight survivors with significant paraquat-induced lung injurys.
Results: High-resolution computed tomography revealed a predominant pattern of irregularly shaped
consolidation with traction bronchiectasis at 1-2 months after paraquat poisoning, a mixed pattern of irregularly
shaped consolidation and ground-glass opacity at 3-12 months, and a mixed pattern of consolidation, ground-
glass opacity, and honeycombing at 1-2 years. At 3-12 months after paraquat ingestion, the areas of consolidation
had markedly decreased and the decreased lung volume had returned to normal. At 1-2 years after paraquat
poisoning, the cystic changes had disappeared. At 2-3 years after paraquat poisoning, the decrease in forced
vital capacity had greatly improved to the normal range.
Conclusions: Recovery of nearly normal pulmonary structure and function may occur over several years
following paraquat poisoning. Pulmonary function (both forced vital capacity and forced expiratory volume in 1
sec) evolved toward normal in the long-term survivors of paraquat poisoning with initial prominent lung injuries.
(Korean J Intern Med 2009;24:95-100)
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INTRODUCTION
Paraquat (1,1’-dimethyl-4,4’-bipyridylium dichloride)
is notorious throughout the world as a potent human
poison. Death typically occurs as a result of progressive
and irreversible pulmonary fibrosis in 5-31 days after
poisoning [1]. Pulmonary involvement has been con-
sidered indicative of a relentlessly progressive disease
with no hope of reversal [2,3]. However, some survivors
with lung injury after paraquat poisoning have been
recently reported [4,5], so elucidating the evolution of
paraquat-induced lung injury has become necessary.
High-resolution computed tomography (HRCT) is an
excellent tool for detecting paraquat-induced lung
injury [6,7]. We have previously described HRCT findings
of lungs in patients less than 1 months after paraquat
poisoning [6]. The predominant finding within the first
7 days is areas of ground-glass attenuation that change
into areas of consolidation associated with bronchiectasis
and areas of irregular lines on follow-up HRCT scans [6]. 
The present study was conducted to observe the evo-
lution of pulmonary injury in long-term survivors after
paraquat intoxication by serial follow-up using HRCT and
pulmonary function tests.METHODS
Study subjects
We retrospectively examined the medical records of
1,189 Korean patients with acute paraquat poisoning
who were admitted to the Institute of Pesticide Poisoning
at Soonchunhyang University Cheonan Hospital (SCH,
Cheonan, Korea; a specialized institute for pesticide
poisoning in Korea) from 1995 to 2001. An initial 682
HRCT scans were obtained 6-8 days (mean, 7 days) after
paraquat poisoning in all 682 patients who survived to
7 days after paraquat exposure. Among them, 191
patients with prominent pulmonary lesions on HRCT
were monitored weekly or monthly with HRCT until the
findings were constant. Follow-up HRCT scans became
stationary before 6 months after paraquat poisoning in
most of the patients.
Only eight patients included in the study had abnormal
pulmonary findings on their initial HRCT scan and had
prominent evolutional changes of the initial findings on
follow-up HRCT scans more than 6 months after paraquat
poisoning: they underwent the last follow-up HRCT
scanning 15-118 months after paraquat poisoning. All
HRCT scans were obtained with one of two scanners
(CT-W 700; Hitachi Medical, Tokyo, Japan; or a GE Pro-
speed; General Electric Medical Systems, Milwaukee, WI,
USA). The HRCT images were reviewed separately by
three experts in paraquat-induced lung lesions and
decisions were reached by consensus. The HRCT findings
were evaluated by duration after paraquat exposure and
categorized into five periods: 1-2 months, 3-12 months,
1-2 years, 2-3 years, and 3-8 years. We also observed the
changes in HRCT findings on serial follow-up HRCT
scans in the same patients. The HRCT findings were eval-
uated by the existence of ground-glass opacity, pulmonary
consoli-dation, bronchiectasis, air trapping, and sub-
pleural lines.
Standardized medical emergency procedures were
conducted according to the Treatment Guideline for
Paraquat Poisoning published by SCH [8]. Briefly,
gastric lavage was performed on all subjects seen within
2 hours after ingestion, and 100 g of Fuller’s earth in 200
mL of 20% mannitol was given if intoxication had
occurred within the previous 12 hours. Extracorporeal
removal was performed if a urinary paraquat test was
positive. All of these procedures were conducted after
obtaining informed consent. The paraquat exposure was
assessed based on the amount of paraquat ingested as
reported by the subject and on a semiquantitative
measure of urine paraquat [9]. Clinical parameters of
PaO2, creatinine, aspartate aminotransferase, alanine
aminotransferase, and amylase were obtained at the time
of the SCH visit and during the follow-up period. Hepatic
dysfunction was defined as either aspartate amino-
transferase or alanine aminotran-sferase >80 IU/L
(double the normal upper limits), renal dysfunction was
defined as serum creatinine >2.0 mg/dL, and pancreatic
dysfunction was defined as blood amylase >320 IU/L
(double the normal upper limit) based on the initial or
follow-up laboratory data. Pulmonary function tests were
performed in seven patients, with both initial and follow-
up tests being performed in five of these patients. This
study was approved by the institutional boards at SCH. 
Statistical analysis
Data are presented as the median and range for con-
tinuous variables and frequency (%) for categorical
variables. We analyzed differences among the time points
in absolute value for the pulmonary function test measures
with the nonparametric Kruskal-Wallis test. A probability
value of p<0.05 was considered statistically significant,
with all statistical analyses performed using SPSS for
Windows (version 10.0; SPSS Inc., Chicago, IL, USA).
RESULTS
The general characteristics of the patients are sum-
marized in  Table 1. Their median age was 35 (18-66)
years, and the male-to-female ratio was 3:5. Three
patients (cases 2, 3, and 6) had unintentionally ingested
a paraquat solution that was in an unlabeled bottle,
and the other five cases were ingested intentionally. All
patients had consumed a 24.5% concentrate of paraquat.
All patients were transferred from other medical facilities
to SCH. The median estimated amount of paraquat
dichloride ingested was 20 (20-120) mL. At SCH, urinary
paraquat was detected in six patients at 42 (2-128) hours
after paraquat ingestion. The average hospital stay was
29 (11-72) days. None of the patients smoked cigarettes
or had a history of pulmonary disease. During the admi-
ssion and follow-up period, liver dysfunction was noted
in 62.5% of patients. All patients had renal dysfunction,
but only one patient had pancreatic dysfunction. Five
patients experienced severe hypoxia (PaO2 <60 mmHg)
during admission. The mean follow-up duration was 39
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December 2003.
Forty-three HRCT scans of the lungs in eight patients
with paraquat poisoning were reviewed. Ground-glass
opacity was observed in all patients 1 week after paraquat
ingestion (Fig. 1A, 2A and 3A). The patterns of 20 HRCT
scans of lungs obtained at 4 weeks after paraquat poisoning
were evaluated (Table 2). The areas of ground-glass
opacity had changed to an irregularly shaped consoli-
dation with traction bronchiectasis at 1-2 months (Fig.
4A; Table 2). A mixed pattern of the irregularly shaped
consolidation and ground-glass opacity was observed at
3-12 months in all patients (Fig. 1B, 2B and 4B; Table 2).
At 1-2 years after paraquat poisoning, irregularly shaped
ground-glass opacity with consolidations was observed
in four patients and honeycombing was seen in two
patients (Fig. 3B and 5B; Table 2).
The areas of consolidation on follow-up HRCT scans
at 3 months after paraquat poisoning had markedly
decreased relative to that at 1-2 months (Fig. 4 and 5).
The small cystic changes with consolidation and the
decrease in lung volume at 3-12 months changed to
honeycombing at 1 year after paraquat poisoning; the
cystic changes disappeared and the lung volumes
increased at 7-8 years after paraquat poisoning (Fig. 2).
The extent of the lung lesions remained unchanged in
the majority of cases, but the irregular consolidation,
especially focal involvement, had disappeared (Fig. 4
and 5). Small cystic changes and focal air trapping were
observed transiently at 1-12 months (Fig. 1 and 2). Subpleural
lines were also observed 3 months to 8 years after paraquat
poisoning (Table 2).
In pulmonary function tests, the forced vital capacity
(FVC) and forced expiratory volume at 1 sec (FEV1)
decreased markedly, and the FEV1/FVC ratio was normal
at 1 month after paraquat poisoning. FVC at more than
2-3 years after paraquat poisoning had significantly
improved (p=0.047, Fig. 6A), but not FEV1(p=0.327,Fig. 6B).
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Table 1. Clinical characteristics of the patients
Case Age Sex PQ
† Urine PQ Organ dysfunction Treatment
(year) (mL) Result Interval (hour)
1 32 F 40 +++ 30 L, K, H GL, F, VC, SOD, HP
2 38 F 20 + 51 L, K, H GL, F, VC, SOD
3 66 F 20 - 128 K VC, SOD
4 49 M 20 - 75 L, K GL, VC, SOD
5 37 F 20 ± 67 L, K, H GL, VC, SOD
6 18 M 20 + 33 L, K, H GL, F, VC, SOD, HP
7 21 M 60 ++++ 4 K, P GL, F, VC, SOD, HP
8 32 F 120 +++ 2 K, H GL, F, VC, SOD, CAVH
Liver dysfunction (L) was defined as either an aspartate aminotransferase or alanine aminotransferase >80 IU/L, kidney dysfunction (K)
was defined as serum creatinine >1.5 mg/dL, hypoxia (H) was defined as PaO2 <60 mmHg, and pancreatic dysfunction (P) was
defined as blood amylase >320 IU/L, all based on the laboratory data obtained at admission and during the follow-up period.
PQ, estimated amount of paraquat ingested; GL, gastric lavage; F, Fuller’s earth; VC, vitamin C; SOD, superoxide dismutase; HP,
hemoperfusion; CAVH, continuous arteriovenous hemofiltration. 
†Amount of PQ ingestion.
Table 2. Follow-up high-resolution computed tomography (HRCT) patterns according to the time after paraquat
poisoning in eight long-term survivors of prominent paraquat-induced lung injuries
HRCT findings
Time Main findings Minor or transient findings
IC IC+IG Honeycombing Air trapping Small cysts Subpleural lines
1-2 months  (n=5) 5 2
3-12 months (n=5) 5 1 3 2
1-2 years  (n=6) 4 2 1
2-3 years  (n=2) 1 1 1
7-8 years  (n=1) 1 1
n, number of patients; IC, irregularly shaped consolidation with traction bronchiectasis; IG, irregularly shaped ground-glass opacities
with traction bronchiectasis.DISCUSSION
Paraquat poisoning is a significant cause of mortality
worldwide, and intentional self-poisoning with paraquat
is a major public health issue in some countries such as
Korea [10]. The main cause of death of acute paraquat
poisoning after 1 week is known to be respiratory dysfun-
ction due to lung damage. In adults, ingestion of paraquat
at 25-35 mg/kg body weight may produce survivable
restrictive pulmonary lesions [11]. Survivors of paraquat
poisoning are left with a permanent restrictive-type of
pulmonary dysfunction, but a long-term follow-up of lung
function has indicated recovery of pulmonary function in
survivors of paraquat poisoning [12].
Little is known regarding long-term changes in lung
structure and function in survivors of acute paraquat
poisoning. The present study is the first serial follow-up of
the structure and function of the lung that has docu-
mented the long-term course of pulmonary damage after
acute paraquat poisoning.
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Figure 3. Representative HRCT findings
in a 38-year-old woman (case 2). (A)
HRCT scan obtained 1 week after
paraquat ingestion shows diffuse ground-
glass opacity in both lungs. (B) HRCT
scan obtained 15 months after paraquat
ingestion shows focal consolidation in the
right upper lobe and honeycombing in the
left upper lobe.
A B
Figure 1. Representative HRCT findings in an 18-year-old man (case 6). (A) HRCT scan obtained 1 week after paraquat ingestion shows
diffuse ground-glass opacity in both upper lobes. (B) HRCT scan obtained 5 months after paraquat ingestion shows irregularly shaped air-
space consolidation in both upper lobes. Air spaces (3 cm) are seen in the anterior periphery of the left upper lobe. (C) HRCT scan obtained 15
months after paraquat ingestion shows irregularly shaped consolidation in the left upper lobe in the absence of air trapping. Focal
consolidation in the right upper lobe of (A) is not evident.
A B C
Figure 2. Representative HRCT findings
in a 32-year-old woman (case 8). (A)
HRCT obtained 1wk after paraquat
ingestion shows ill-defined diffuse
ground-glass opacity in both lungs. (B)
HRCT scan obtained 6 months after
paraquat ingestion shows air-space con-
solidations with small cystic changes and
traction bronchiectasis in the decreased
left lung. Focal consolidation is seen in the
anterior periphery of the right middle
lobe. Subpleural lines are seen in the
posterior periphery of the right upper
lobe. (C) HRCT scan obtained 27 months
after paraquat ingestion shows localized
honeycombing in the left lung. Irregularly
shaped consolidations in the left lung on
(B) have decreased markedly. (D) HRCT scan
obtained 7 years after paraquat ingestion
shows multifocal honeycombing.
A B
C DHRCT findings in lungs less than 1 month after paraquat
poisoning have already been described [6]. Our findings
were similar in that the initial areas of ground-glass
attenuation within the first 7 days changed into areas of
consolidation associated with bronchiectasis on follow-up
HRCT scans [6] less than 1 month after paraquat
poisoning. However, our HRCT findings from more than 1
months after paraquat poisoning and serial follow-up are
the first to be reported. A surprising finding in the present
study was that the consolidations had markedly decreased,
the cystic changes had disappeared, and the decreased
lung volume had returned to normal at 3-12 months after
paraquat ingestion. The extent of paraquat-induced lung
lesions remained unchanged in the majority of cases, but
the irregular consolidations, especially focal involvement,
had disappeared. The transient HRCT findings after
paraquat ingestion were small cysts, focal air trapping,
and subpleural lines. The small cysts were observed in two
cases at 1-12 months after paraquat exposure, and focal air
trapping was observed in one case at 3-12 months. Im et al
[7] observed small cysts and linear opacity at 2-4 weeks
and focal honeycombing at 4 weeks on simple chest X-
rays.
The FVCs of our patients with severe paraquat poi-
soning dramatically and significantly recovered after
2-3 years. The lag time to recovery was longer than in a
previous case study [13], but this difference may have
been attributable to more severe paraquat-induced lung
dysfunction in our cases.
Based on the long-term follow-ups of the cases presented
here, recovery of normal or nearly normal pulmonary
structure and function is possible over several years. When
considering possible mechanisms for this unanticipated
pulmonary recovery, the most likely hypothesis is that
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Figure 6. Pulmonary function test results according to the time
after paraquat poisoning in long-term survivors of prominent
paraquat-induced lung injuries. (A) FVC, forced vital capacity,
*p=0.047; (B) FEV1, forced expiratory volume in 1 sec, p=0.327.
Statistical analyses were performed with the nonparametric
Kruskal-Wallis test.
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Figure 4. Representative HRCT findings
in a 32-year-old woman (case 1). (A)
HRCT scan obtained 1 month after
paraquat ingestion shows irregularly
shaped multifocal air-space consolidation
with traction bronchiectasis in both lower
lobes. (B) HRCT scan obtained 11 months
after paraquat ingestion at the same level
as in (A) shows that irregularly shaped
multifocal air-space consolidations have
changed to irregularly shaped multifocal
ground-glass opacities. However, the
extent of the lesions had not changed.
A B
Figure 5. Representative HRCT findings
in a 37-year-old woman (case 5). (A)
HRCT scan obtained 2 weeks after
paraquat ingestion shows diffuse ground-
glass opacity in the left lung and focal
ground-glass opacity in the right lung. (B)
HRCT scan obtained 20 months after
paraquat ingestion shows subpleural lines
in the posterior portion of the left upper
lobe, but bilateral consolidation is not
evident.
A Ban inflammatory factor is present during the acute phase
of the poisoning, predisposing one to the early onset of
pulmonary fibrosis, which may improve over time [14].
Our study had several limitations, although we do not
believe that they invalidate its conclusions. First, we did
not measure plasma paraquat levels in all cases, which
may have more accurately reflected the severity of
paraquat exposure. However, we and others observed the
significant relationship between plasma paraquat
concentration and urine paraquat concentration employed
in the present study [15,16]. Second, we could not correlate
HRCT and pathology due to serial examination of the lung
pathology. In a previous study, we observed interstitial
fibrosis and mononuclear cell infiltration on lung tissue
and ground-glass opacity in patients 1 weeks after paraquat
exposure [6]. The complete resolution of the ground-glass
opacity on HRCT over time has been reported in amio-
darone-induced lung disease [17]. Therefore, we believe
the areas of consolidation with bronchiectasis on HRCT
scans obtained at 1-2 months revert to normal or near-
normal structure.
In conclusion, typical long-term HRCT findings of the
lung after paraquat poisoning were irregularly shaped
pulmonary consolidation at 1-2 months after paraquat
exposure, and mixed patterns of irregularly shaped
pulmonary consolidation and ground-glass opacity or
honeycombing at 3-12 months. The attenuation of the pul-
monary consolidation began in all patients at 3-12
months and the focal pulmonary consolidation may have
disappeared during this period. Therefore, progressive
pulmonary fibrosis was not seen in long-term survivors
after acute paraquat poisoning in the present study. Our
findings suggest that paraquat-induced lung injury
may not be irreversible or progressive. Not only did lung
volume increase, lung function also improved over time
in long-term survivors of paraquat poisoning with pro-
minent lung injuries.
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